The present specification generally relates to the field of sterile biofabrication.
Biofabrication is becoming more common in the additive manufacturing fields and readily available within the life sciences, medical, and pharmaceutical research fields, in both academic and commercial sectors.
Some current bioprinting platforms for biofabrication may contain filtration systems. However, these filtration systems often do not guarantee sterility and laminar flow within the workspace. This is especially true if the doors to such a filtered workspace are opened for a period of time. Moreover, these platforms and filtration systems often rely on human action as the biofabrication product is moved through the workflow, e.g. from one station to another. This human action, or human intervention, increases the likelihood of contamination to the biofabrication product.
Additional features and advantages of the present disclosure will be set forth in the detailed description, which follows, and in part will be apparent to those skilled in the art from that description or recognized by practicing the embodiments described herein, including the detailed description, which follows the claims, as well as the appended drawings.
In a first aspect A1, a biofabrication system includes a biosafety cabinet, a workstation, and an articulating arm. The biosafety cabinet includes an integration port that provides access to a work area within the biosafety cabinet through a wall of the biosafety cabinet. The workstation is disposed within the work area of the biosafety cabinet and includes a stage configured for biofabrication. The articulating arm is disposed within the work area of the biosafety cabinet and is positioned to reach the workstation and the integration port.
In a second aspect A2 according to the first aspect A1, the integration port is positioned at a back wall of the biosafety cabinet.
In a third aspect A3 according to any preceding aspect, the biosafety cabinet maintains a positive pressure at the integration port such that air may pass out the biosafety cabinet through the integration port but is prevented from passing into the biosafety cabinet through the integration port.
In a fourth aspect A4 according to any preceding aspect, the biosafety cabinet further includes a cabling panel through a back wall of the biosafety cabinet.
In a fifth aspect A5 according to any preceding aspect, the biofabrication system further includes a conveyer positioned to extend into the biosafety cabinet through the integration port.
In a sixth aspect A6 according to any preceding aspect, the biofabrication system further includes a second articulating arm disposed outside of the biosafety cabinet and configured to pass an item into the biosafety cabinet via the integration port.
In a seventh aspect A7 according to the sixth aspect A6, the biofabrication system further includes a second station, wherein the second articulating arm is configured to pass the item from the second station and into the biosafety cabinet via the integration port.
In an eighth aspect A8 according to any preceding aspect, the biosafety cabinet includes a sash and defines an opening into the biosafety cabinet beneath the sash.
In a ninth aspect A9 according to any preceding aspect, the workstation is coupled to the biosafety cabinet such that the workstation may be tilted upward.
In a tenth aspect A10 according to any preceding aspect, the biosafety cabinet is supported by legs having adjustable height.
In an eleventh aspect A11 according to any preceding aspect, the workstation includes an end effector bay.
In a twelfth aspect A12 according to any preceding aspect, the workstation includes a temperature sensor configured and positioned to measure an air temperature within the work area.
In a thirteenth aspect A13, a method of biofabrication includes printing a bioproduct on a stage of a biofabrication system. The biofabrication system includes a biosafety cabinet, a workstation, and an articulating arm. The biosafety cabinet includes an integration port that provides access to a work area within the biosafety cabinet through a wall of the biosafety cabinet. The workstation is disposed within the work area of the biosafety cabinet and includes a stage configured for biofabrication. The articulating arm is disposed within the work area of the biosafety cabinet and is positioned to reach the workstation and the integration port.
In a fourteenth aspect A14 according to the thirteenth aspect A13, the method further includes maintaining a positive pressure at the integration port such that air may pass out the biosafety cabinet through the integration port but is prevented from passing into the biosafety cabinet through the integration port.
In a fifteenth aspect A15 according to the thirteenth aspect A13 or the fourteenth aspect A14, the method further includes transferring the bioproduct out of the biosafety cabinet using the articulating arm.
In a sixteenth aspect A6 according to the fifteenth aspect A15, the transferring the bioproduct includes positioning the bioproduct on a conveyer using the articulating arm, wherein the conveyer extends through the integration port.
In a seventeenth aspect A17 according to the sixteenth aspect A16, the method further includes transferring the bioproduct to a second station using a second articulating arm.
In an eighteenth aspect A18, a method of biofabrication includes receiving an item through an integration port of a biofabrication system and moving the item from the integration port to a workstation with an articulating arm. The biofabrication system includes the integration port, the workstation, and the articulating arm. The integration port provides access to a work area within the biosafety cabinet through a wall of the biosafety cabinet. The workstation is disposed within the work area of the biosafety cabinet and includes a stage configured for biofabrication. The articulating arm is disposed within the work area of the biosafety cabinet and is positioned to reach the workstation and the integration port.
In a nineteenth aspect A19 according to the eighteenth aspect A18, the method further includes maintaining a positive pressure at the integration port such that air may pass out the biosafety cabinet through the integration port but is prevented from passing into the biosafety cabinet through the integration port.
In a twentieth aspect A20 according to the eighteenth aspect A18 or the nineteenth aspect A19, the receiving the item through the integration port includes transporting the item on a conveyer extending through the integration port.
The embodiments set forth in the drawings are illustrative and exemplary in nature and not intended to limit the subject matter defined by the claims. The following detailed description of the illustrative embodiments can be understood when read in conjunction with the following drawings, where like structure is indicated with like reference numerals and in which:
Additional features and advantages of the present disclosure will be set forth in the detailed description, which follows, and in part will be apparent to those skilled in the art from that description or recognized by practicing the embodiments described herein, including the detailed description, which follows the claims, as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description describe various embodiments and are intended to provide an overview or framework for understanding the nature and character of the claimed subject matter. The accompanying drawings are included to provide a further understanding of the various embodiments and are incorporated into and constitute a part of this specification. The drawings illustrate the various embodiments described herein, and together with the description, explain the principles and operations of the claimed subject matter.
Reference will now be made in detail to various embodiments of devices, assemblies, and methods, examples of which are illustrated in the accompanying drawings. Whenever possible, the same reference numerals will be used throughout the drawings to refer to the same or like parts. The present disclosure generally relates to a biofabrication system that includes a workstation and an articulating arm disposed within a work area of a biosafety cabinet. The workstation may include a stage for biofabrication. The biosafety cabinet may include an integration port that provides access to the work area through a wall of the biosafety cabinet. The articulating arm may be positioned to reach the workstation and the integration port. In this way, the articulating arm may receive or send out an item, such as a bioproduct, through the integration port and may move the item about the workstation without sacrificing the laminar flow or sterile environment of the biosafety cabinet. In some embodiments, the laminar flow and sterile environment may be maintained within the work area of the biosafety cabinet even when the integration port remains fully open.
Directional terms as used herein—for example up, down, right, left, front, back, top, bottom—are made only with reference to the figures as drawn and are not intended to imply absolute orientation unless otherwise specified.
The term “biofabrication” is used herein to refer generally to the processes of bioprinting, biomanufacturing, bioassembly, and the like. As used herein, biofabrication may include automated and partially automated processes that generate or assist in generating products made from living cells, bioactive molecules, biomaterials, and the like.
Unless otherwise expressly stated, it is in no way intended that any method set forth herein be construed as requiring that its steps be performed in a specific order, nor that with any apparatus specific orientations be required. Accordingly, where a method claim does not actually recite an order to be followed by its steps, or that any device or assembly claim does not actually recite an order or orientation to individual components, or it is not otherwise specifically stated in the claims or description that the steps are to be limited to a specific order, or that a specific order or orientation to components of an device or assembly is not recited, it is in no way intended that an order or orientation be inferred, in any respect. This holds for any possible non-express basis for interpretation, including: matters of logic with respect to arrangement of steps, operational flow, order of components, or orientation of components; plain meaning derived from grammatical organization or punctuation; and the number or type of embodiments described in the specification.
As used herein, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a” component includes aspects having two or more such components, unless the context clearly indicates otherwise.
Referring to
Still referring to
Referring to
The integration port 114 may also be an opening into the work area 106. As will be described in greater detail herein, the integration port 114 may enable transfer of work pieces (not depicted) into and out of the work area 106 while maintaining the sterile environment within the work area 106. The biosafety cabinet 100 may maintain a positive pressure at the integration port 114 such that air and/or contaminants from outside of the biosafety cabinet 100 may not enter the work area 106. Accordingly, by maintaining this positive pressure, the integration port 114 may remain open during use of the biosafety cabinet 100 without contaminating the work area 106, without allowing air from the work area 106 to exit the biosafety cabinet 100, and without sacrificing the laminar flow within the biosafety cabinet 100. In some embodiments, the integration port 114, may include a door configured to open and close the integration port 114. In some embodiments, such a door may be automated to open and close, for example by using a motion sensor.
Still referring to
In embodiments, the workstation 140 may be configured for biofabrication. Accordingly, the workstation 140 may include a plurality of features, such as, for example, an end effector bay 142, a stage 144, which may be a printing stage or a tissue assembly stage, and a dispensing tip calibration system 146. The workstation 140 may include additional and/or alternative features other than those described. In some embodiments, the workstation 140 may be similar to the BioAssemblyBot 400 (BAB400, Advanced Solutions Life Sciences, Louisville, Ky.) platform (see, for example, U.S. Pat. Nos. 9,910,935 and 10,838,404, incorporated herein by reference in their entirety). In some embodiments, the workstation 140 may include sensors and other equipment for environmental sensing and logging of metrics such as air temperature, relative humidity, ambient pressure, and ambient CO2 concentration. For example, the workstation 140 may include a temperature sensor configured and positioned to measure an air temperature within the work area 106. In some embodiments, and as depicted, for example, in
Referring back to
Still referring to
Referring now to
Still referring to
In view of the above, it should now be understood that at least some embodiments of the present disclosure are directed to a biofabrication system that includes a workstation and an articulating arm disposed within a work area of a biosafety cabinet. The workstation may include a stage, such as a printing stage or a tissue assembly stage, for biofabrication or, more specifically, bioprinting or assembly of a bioproduct. The biosafety cabinet may include an integration port that provides access to the work area through a wall of the biosafety cabinet. The articulating arm may be positioned to reach the workstation and the integration port. In this way, the articulating arm may receive or send out an item through the integration port and may move the item about the workstation without sacrificing the laminar flow or sterile environment of the biosafety cabinet. In some embodiments, the laminar flow and sterile environment may be maintained within the work area of the biosafety cabinet even when the integration port remains fully open.
It is noted that the terms “substantially” and “about” may be utilized herein to represent the inherent degree of uncertainty that may be attributed to any quantitative comparison, value, measurement, or other representation. These terms are also utilized herein to represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue.
While particular embodiments have been illustrated and described herein, it should be understood that various other changes and modifications may be made without departing from the spirit and scope of the claimed subject matter. Moreover, although various aspects of the claimed subject matter have been described herein, such aspects need not be utilized in combination. It is therefore intended that the appended claims cover all such changes and modifications that are within the scope of the claimed subject matter.
This application claims priority to U.S. Provisional Application Ser. No. 63/181,040 filed on Apr. 28, 2021, the entire disclosure of which is hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
63181040 | Apr 2021 | US |